Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ODN 2216 is a TLR9 (toll-like receptor 9) ligand or agonist that induces the production of large amounts of IFN-α and IFN-β. ODN 2216 can induce IFN-α using pDC (plasma cell-like DC) and IL-12 (p40) using DC (dendritic cells). ODN 2216 is capable of indirectly stimulating IFN-γ production by peripheral blood mononuclear cells (PBMC), mediated by IFN-α/β. ODN 2216 activates NK cells and induces IFN-γ production by TCR-triggered CD4+ T cells.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | 10-14 weeks | $ 1,530.00 | |
25 mg | 10-14 weeks | $ 2,649.00 |
Description | ODN 2216 is a TLR9 (toll-like receptor 9) ligand or agonist that induces the production of large amounts of IFN-α and IFN-β. ODN 2216 can induce IFN-α using pDC (plasma cell-like DC) and IL-12 (p40) using DC (dendritic cells). ODN 2216 is capable of indirectly stimulating IFN-γ production by peripheral blood mononuclear cells (PBMC), mediated by IFN-α/β. ODN 2216 activates NK cells and induces IFN-γ production by TCR-triggered CD4+ T cells. |
Molecular Weight | N/A |
CAS No. | 332437-00-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ODN 2216 332437-00-0 inhibitor inhibit